Titan Confirms District-Wide Germanium Enrichment as Critical Mineral Push Expands at Empire State Mines
GOUVERNEUR, N.Y., July 07, 2026 (GLOBE NEWSWIRE) — Titan Mining Corporation (NYSE-A:TII, TSX:TI), (“Titan” or the “Company”) an existing zinc concentrate producer in upstate New York and the only end to end producer of natural flake graphite in the U.S., today provided an update
GOUVERNEUR, N.Y., July 07, 2026 (GLOBE NEWSWIRE) -- Titan Mining Corporation (NYSE-A:TII, TSX:TI), (“Titan” or the “Company”) an existing zinc concentrate producer in upstate New York and the only end to end producer of natural flake graphite in the U.
S., today provided an update on its germanium (Ge) evaluation program at its 100%-owned Empire State Mines property. A property-wide reconnaissance program has confirmed elevated germanium across the Balmat-Edwards mineral system, in both primary zinc ore and historic tailings, establishing district-wide enrichment as a characteristic of the system rather than a localized occurrence.
Read More
Đọc thêm từ Tài chính
Beyond payments: India aims to architect Indonesia’s digital future
India’s wildly popular digital payments system, which began as a way for people to send money instantly by phone, could help the country turn one of its biggest domestic technology successes into a tool of diplomacy, analysts say. That opportunity is coming into focus in Indonesi
Half of Americans struggle to afford groceries and gas, exclusive poll finds
About 57% of polled Americans also believe economy is worsening in grim portrait of cost of living crisis, according to Harris survey for the GuardianNinety-five per cent of Americans believe the US is suffering an affordability crisis, as many report trouble with the rising cost
Why these global stocks with a high barrier to entry are winning the war on AI disruption
Goldman Sachs says the HALO trade has worked well this year, but a tougher phase relying on earnings performance lies ahead.
Vertex signs agreement to acquire Crinetics for $10bn
Vertex has signed a definitive agreement to purchase Crinetics Pharmaceuticals in a transaction valued at nearly $10bn, or $8.8bn net of estimated cash acquired. Approved unanimously by both companies' boards, the acquisition will see Vertex pay $85.